Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam

Introduction: ADVANCE was a large, multinational clinical study conducted over 5 years in type 2 diabetes mellitus (T2DM). In all, 11,140 patients were randomly assigned to receive gliclazide-based intensive glucose control (IGC) or standard glucose control (SGC). IGC was shown to significantly redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen-Thi, Hai-Yen, Nguyen, Nga TQ., Le, Nguyen Dang Tu, Beillat, Maud, Ethgen, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661634/
https://www.ncbi.nlm.nih.gov/pubmed/33194963
http://dx.doi.org/10.3389/fpubh.2020.562023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661634/
https://www.ncbi.nlm.nih.gov/pubmed/33194963
http://dx.doi.org/10.3389/fpubh.2020.562023

Ejemplares similares